Clinical Trial

A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aβ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A multicenter phase III clinical study evaluating the diagnostic performance and safety of PET for the deposition of Aβ plaques in the brain of participants with normal cognitive function, MCI and AD using \[18F\]Fluorbetazine injection.
Trial Details
NCT Number NCT07764679
Lead Sponsor HTA Co., Ltd.
Conditions Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD)
Enrollment 400 participants
Start Date 2025-06-20
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14